Radiology, Vol 192, 687-690, Copyright © 1994 by Radiological Society of North America

ARTICLES

Chemoembolization of hepatocellular carcinoma in patients who undergo liver transplantation

C Spreafico, A Marchiano, E Regalia, LF Frigerio, F Garbagnati, S Andreola, M Milella, R Lanocita and V Mazzaferro
Department of Radiology, National Cancer Institute of Milan, Italy.

PURPOSE: To determine the efficacy of chemoembolization (CHE) for hepatocellular carcinoma (HCC) in patients with a cirrhotic liver. MATERIALS AND METHODS: Twenty-one patients with cirrhosis and 33 HCC nodules received a mean of 2.4 cycles of CHE before orthotopic liver transplantation (OLT). Iodized oil plus doxorubicin (13 patients) or mitoxantrone (eight patients) was injected into the hepatic artery. Twelve (57%) of the patients underwent terminal embolization with gelatin sponge pledgets. After OLT, the percentage of tumor necrosis was assessed in each HCC nodule. RESULTS: Twelve (36%) of 33 HCC nodules responded completely to CHE (necrosis > 90%). Successful treatment was statistically significantly related to nodular diameter greater than 2 cm (P = .03), solitariness (P = .0009), hypervascularity (P = .001), and good retention of iodized oil (P = .05). Seven (33%) of the patients had major complications; no death occurred in association with CHE. All patients survived OLT; in three patients (14%), HCC recurred a median of 21 months after OLT. CONCLUSION: CHE seems to be an effective treatment for HCC in patients with liver cirrhosis who await OLT.

This article has been cited by other articles:

				E. Alba, C. Valls, J. Dominguez, L. Martinez, E. Escalante, L. Llado, and T. Serrano Transcatheter Arterial Chemoembolization in Patients with Hepatocellular Carcinoma on the Waiting List for Orthotopic Liver Transplantation Am. J. Roentgenol., May 1, 2008; 190(5): 1341 - 1348. [Abstract] [Full Text] [PDF]

				S. C. A. Herber, G. Otto, J. Schneider, M. Schuchmann, C. Duber, M. B. Pitton, I. Kummer, and N. Manzl Transarterial Chemoembolization in Patients Not Eligible for Liver Transplantation: Single-Center Results Am. J. Roentgenol., April 1, 2008; 190(4): 1035 - 1042. [Abstract] [Full Text] [PDF]

				R. T. P. Poon, K. K. C. Ng, C.-M. Lam, V. Ai, J. Yuen, and S.-T. Fan Effectiveness of Radiofrequency Ablation for Hepatocellular Carcinomas Larger Than 3 cm in Diameter Arch Surg, March 1, 2004; 139(3): 281 - 287. [Abstract] [Full Text] [PDF]

				S. Sumie, F. Yamashita, E. Ando, M. Tanaka, Y. Yano, K. Fukumori, and M. Sata Interventional Radiology for Advanced Hepatocellular Carcinoma: Comparison of Hepatic Artery Infusion Chemotherapy and Transcatheter Arterial Lipiodol Chemoembolization Am. J. Roentgenol., November 1, 2003; 181(5): 1327 - 1334. [Abstract] [Full Text] [PDF]

				K. Stuart Chemoembolization in the Management of Liver Tumors Oncologist, October 1, 2003; 8(5): 425 - 437. [Abstract] [Full Text] [PDF]

				T. Livraghi, S. N. Goldberg, S. Lazzaroni, F. Meloni, T. Ierace, L. Solbiati, and G. S. Gazelle Hepatocellular Carcinoma: Radio-frequency Ablation of Medium and Large Lesions Radiology, March 1, 2000; 214(3): 761 - 768. [Abstract] [Full Text]

				R. Pichlmayr, A. Weimann, G. Tusch, and H. J. Schlitt Indications and Role of Liver Transplantation for Malignant Tumors Oncologist, June 1, 1997; 2(3): 164 - 170. [Abstract] [Full Text] [PDF]

				V. Mazzaferro, E. Regalia, R. Doci, S. Andreola, A. Pulvirenti, F. Bozzetti, F. Montalto, M. Ammatuna, A. Morabito, and L. Gennari Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis N. Engl. J. Med., March 14, 1996; 334(11): 693 - 700. [Abstract] [Full Text] [PDF]